These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 3524205)
1. Renal disease and drug metabolism: an overview. Gibson TP Am J Kidney Dis; 1986 Jul; 8(1):7-17. PubMed ID: 3524205 [TBL] [Abstract][Full Text] [Related]
2. Modeling and predicting drug pharmacokinetics in patients with renal impairment. Rowland Yeo K; Aarabi M; Jamei M; Rostami-Hodjegan A Expert Rev Clin Pharmacol; 2011 Mar; 4(2):261-74. PubMed ID: 22115405 [TBL] [Abstract][Full Text] [Related]
3. Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs. Yuan R; Venitz J Int J Clin Pharmacol Ther; 2000 May; 38(5):245-53. PubMed ID: 10839468 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics in renal disease. Levy G Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113 [TBL] [Abstract][Full Text] [Related]
5. Consequences of renal insufficiency on the hepatic clearance of some drugs. Balant LP; Dayer P; Fabre J Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317 [TBL] [Abstract][Full Text] [Related]
6. The effect of chronic renal failure on hepatic drug metabolism and drug disposition. Dreisbach AW; Lertora JJ Semin Dial; 2003; 16(1):45-50. PubMed ID: 12535300 [TBL] [Abstract][Full Text] [Related]
8. Renal failure, drug pharmacokinetics and drug action. Fabre J; Balant L Clin Pharmacokinet; 1976; 1(2):99-120. PubMed ID: 13956 [TBL] [Abstract][Full Text] [Related]
9. The Role of the Kidney in Drug Elimination: Transport, Metabolism, and the Impact of Kidney Disease on Drug Clearance. Miners JO; Yang X; Knights KM; Zhang L Clin Pharmacol Ther; 2017 Sep; 102(3):436-449. PubMed ID: 28599065 [TBL] [Abstract][Full Text] [Related]
10. Quantitative Assessment of the Effect of Chronic Kidney Disease on the Nonrenal Clearance of 10 Drugs After Intravenous Administration. Hinderling PH; Yu Y Clin Pharmacol Drug Dev; 2019 Feb; 8(2):138-151. PubMed ID: 30589517 [TBL] [Abstract][Full Text] [Related]
11. Drug metabolism in chronic renal failure. Pichette V; Leblond FA Curr Drug Metab; 2003 Apr; 4(2):91-103. PubMed ID: 12678690 [TBL] [Abstract][Full Text] [Related]
13. [Renal function and pharmacotherapy in children]. Jovanović O Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():15-21. PubMed ID: 18193796 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function. Lavene D; Weiss YA; Safar ME; Loria Y; Agorus N; Georges D; Milliez PL J Clin Pharmacol; 1977; 17(8-9):501-8. PubMed ID: 893736 [TBL] [Abstract][Full Text] [Related]
16. [Characteristics of the pharmacokinetics of drugs in renal failure]. Nadzhimutdinov KN; KrakovskiÄ ME Farmakol Toksikol; 1985; 48(5):109-13. PubMed ID: 3908139 [No Abstract] [Full Text] [Related]
17. Prediction of drug dosage in patients with renal failure using data derived from normal subjects. Welling PG; Craig WA; Kunin CM Clin Pharmacol Ther; 1975 Jul; 18(1):45-52. PubMed ID: 1149361 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of changes in drug elimination in children. Prandota J Dev Pharmacol Ther; 1985; 8(5):311-28. PubMed ID: 3899553 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications. Klotz U Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498 [TBL] [Abstract][Full Text] [Related]
20. Can non-renal clearance and/or bioavailability of drugs be assessed reliably in renal impairment studies with oral drug administration? Yu Y; Hinderling PH Int J Clin Pharmacol Ther; 2024 Mar; 62(3):129-141. PubMed ID: 38174884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]